NCT05968690 2025-09-18Naltrexone and Propranolol Combined With ImmunotherapyRutgers, The State University of New JerseyPhase 1 Recruiting12 enrolled
NCT03384836 2025-07-02Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by SurgeryRoswell Park Cancer InstitutePhase 1/2 Suspended47 enrolled